Product How it works Pricing Blog FAQ About Contact
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals (NASDAQ: AMLX) revenue

Amylyx Pharmaceuticals reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($87.4m).

Amylyx Pharmaceuticals's revenue has fallen for 2 years in a row, and its best year of the last 5 was fiscal 2023. The biggest drop was in fiscal 2024, −77.1%.

Revenue, in millions of US dollars0.3202122.22022380.8202387.420240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m−100.0%−$153.3m—
2024$87.4m−77.1%−$314.7m−360.2%
2023$380.8m+1,612.9%$38.8m10.2%
2022$22.2m+7,700.0%−$201.3m−905.7%
2021$0.3m—−$82.7m−29,013.3%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Amylyx Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Amylyx Pharmaceuticals ranks 403rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Amylyx Pharmaceuticals, −100.0%.

RankCompanyRevenueRevenue growth
401stAltimmune$0.0m105.0%
402ndLyell Immunopharma$0.0m−41.0%
403rdAmylyx Pharmaceuticals$0.0m−100.0%
404thArtiva Biotherapeutics$0.0m−100.0%
405thCapricor Therapeutics$0.0m−100.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Amylyx Pharmaceuticals

How much revenue did Amylyx Pharmaceuticals make in fiscal 2025?
Amylyx Pharmaceuticals reported revenue of $0.0m for fiscal 2025, compared with $87.4m in fiscal 2024.
What was the best year for revenue at Amylyx Pharmaceuticals?
Of its last 5 fiscal years, fiscal 2023, with $380.8m.
Where does Amylyx Pharmaceuticals rank in its sector by revenue?
It ranks 403rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Amylyx Pharmaceuticals come from?
From the annual report (Form 10-K) that Amylyx Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Amylyx Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Amylyx Pharmaceuticals: the Amylyx Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.